Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle
Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle
Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2.9%<br />
R&D expenditure<br />
(% of GDP, 2004)<br />
Established cluster<br />
Switzerland<br />
3,436<br />
Researchers in<br />
R&D (per million<br />
people, 2003)<br />
Academic excellence, high-profile education programs and the high quality<br />
of life render Switzerland not only very competitive in the global market for<br />
life sciences talent, but increasingly at the entrepreneurial level too.<br />
Overview<br />
25.0%<br />
High technology<br />
exports (% overall<br />
exports, 2009)<br />
75 EMEA | <strong>Jones</strong> <strong>Lang</strong> <strong>LaSalle</strong><br />
11.3%<br />
Total health<br />
expenditure<br />
(% of GDP, 2009)<br />
Switzerland is one of Europe’s most established life sciences<br />
locations. For the second year running, Switzerland was<br />
rated number one in the World Economic Forum’s <strong>Global</strong><br />
Competitiveness <strong>Report</strong> 2010–<strong>2011</strong>, reflecting its advantages<br />
for the life science industry and other research, production and<br />
service companies. Switzerland is also a leader in education<br />
and is one of the world’s most active countries in research.<br />
The density of biotech companies in Switzerland is unparalleled<br />
world-wide. Its life sciences companies range from large<br />
multinational corporations such as Merck Serono, Novartis<br />
and Roche to innovative start-ups.<br />
The main clusters of life science activity can be found in Basel<br />
(BioValley), Zurich (Greater Zurich Area) and in Geneva (BioAlps).<br />
1<br />
World economic<br />
forum’s innovation<br />
rank (out of 142)<br />
There, the highly concentrated presence of the life sciences<br />
industry, universities and government assistance for spin-offs<br />
support the vibrant life sciences activities in these areas.<br />
Aided by the proximity of top pharmaceutical companies such as<br />
Roche and Novartis and by the strong financial sector in Zurich,<br />
academic excellence in the biomedical sciences serves as a<br />
motor for innovation in the biotech and medtech sector.<br />
Joint activities of universities and private companies provide<br />
favorable conditions for young start-up companies. Benefits such<br />
as low-cost rental space at the university’s labs during the first<br />
years and the availability of biotech parks and business incubators<br />
in and around Zurich also support life sciences growth.<br />
Tof C